All stock lists
Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
Israel · Delayed Price · Currency is USD
Healthcare · Drug Manufacturers - Specialty & Generic
39.83+0.41 (+1.05%)
Insider Score
––Not scored
TEVA Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
TEVA Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 4.14 B | 3.98 B | 4.71 B | 4.48 B | 4.18 B | 3.89 B |
| Revenue Growth (YoY) | -0.81 % | 2.31 % | 11.40 % | 3.44 % | 0.29 % | 1.89 % |
| Cost of Revenue | 1.99 B | 2.01 B | 2.06 B | 2.18 B | 2.07 B | 2.01 B |
| Gross Profit | 2.15 B | 1.97 B | 2.66 B | 2.30 B | 2.10 B | 1.88 B |
| SG&A Expense | 1.03 B | 1.00 B | 1.12 B | 973.00 M | 959.00 M | 919.00 M |
| R&D Expense | 250.00 M | 222.00 M | 267.00 M | 256.00 M | 244.00 M | 247.00 M |
| Operating Expenses | 2.00 B | 1.32 B | 2.35 B | 1.42 B | 1.65 B | 1.36 B |
| Operating Income | 149.00 M | 652.00 M | 300.00 M | 882.00 M | 455.00 M | 519.00 M |
| Pretax Income | -455.00 M | 436.00 M | 91.00 M | 648.00 M | 204.00 M | 294.00 M |
| Tax Provision | 121.00 M | 67.00 M | -390.00 M | 214.00 M | -78.00 M | 74.00 M |
| Net Income | -576.00 M | 369.00 M | 480.00 M | 433.00 M | 282.00 M | 214.00 M |
| EPS (Basic) | -0.49 | 0.32 | 0.42 | 0.38 | 0.25 | 0.19 |
| EPS (Diluted) | -0.49 | 0.31 | 0.41 | 0.37 | 0.24 | 0.18 |
| Shares Outstanding | 1.17 B | 1.16 B | 1.15 B | 1.15 B | 1.15 B | 1.14 B |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.